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学位論文内容の要旨 
Malaria is still one of the most frightening parasitic diseases in the world. Exploring new drugs to meet the needs 
against drug-resistant diseases is an everlasting topic in the theraptic practice. Plants are still an important resource for 
the discovery of new drugs. The author thus paid her attention to modify the indoloquinoline scaffolds and evaluate 
biological activities of their derivatives as antimalarial and anticancer agents. 
1) The author described the synthesis of 6-methyl-5H-indolo[2,3-b]quinoline and evaluated their antimalarial activity 
against P.falciparum (NF54), cytotoxicity toward L6 cells and -haematin inhibition activity. Introduction of Me 
group at N6 and modification to the urea and thiourea derivatives were not favorable for antimalarial activity, but the 
cytotoxicity was improved against normal cells. 
2) Author developed a feasible method to introduce the methyl group to at N11 of indolo[3,2-c]quinoline, affording the 
C6-alkylamino analogues. At the same time, the author compared the amination reactivity at the C6 of 
6-chloro-11-methyl-indolo[3,2-c]quinoline and 6-chloro-11H-indolo[3,2-c]quinolines.  
3) A series of 11H- and 11Me-indolo[3,2-c]quinoline derivatives were synthesized, modified them with various 
alkylamino groups at C6 along with various substituents at C2. The anticancer activities of them in vitro were tested 
against MV4-11 (human leukemia), A549 (non-small cell lung cancer) and HCT116 (colon cancer) and BALB/3T3 
(normal murine fibroblasts). All the N11 methylated compounds significantly increased the anticancer activity, and 
also exhibited a selective activity.  
4) All the indolo[3,2-c]quinoline derivatives showed potent antimalarial activity against the CQS strain (NF54) and the 
CQR strain (K1) in vitro. The chlorine atom at C2 and urea derivatives  increased activity against the CQS strain 
(NF54). The methyl branched pendant decreased cytotoxicity and increased antimalarial activity. The linear 
correlation analysis revealed that there were three contributing factors, namely water solubility, hydrophilic surface 
area, and β-haematin inhibition that influence biological activity of this series against CQS (NF54) parasites. 
5) The artemisinin-indoloquinoline hybrids were synthesized and screened for antimalarial activity against two different 
strains (CQS: NF54 and CQR: K1) and the cytotoxicity activity against normal L6 cells were evaluated. All hybrids 
showed significant antimalarial activity and β-haematin inhibition activity. 
  
論文審査結果の要旨 
 
 Malaria is still one of the most frightening parasitic diseases in the world. Exploring new 
drugs to meet the needs against drug-resistant diseases is an everlasting topic in the theraptic 
practice. Plants are still an important resource for the discovery of new drugs. The author thus paid 
her attention to modify the indoloquinoline scaffolds and evaluate biological activities of their 
derivatives as antimalarial and anticancer agents. 
1) Author developed a feasible method to introduce the methyl group to at N11 of 
indolo[3,2-c]quinoline, affording the C6-alkylamino analogues. At the same time, the author 
compared the amination reactivity at the C6 of 6-chloro-11-methyl-indolo[3,2-c]quinoline and 
6-chloro-11H-indolo[3,2-c]quinolines.  
2) A series of 11H- and 11Me-indolo[3,2-c]quinoline derivatives were synthesized, modified them 
with various alkylamino groups at C6 along with various substituents at C2. The anticancer 
activities of them in vitro were tested against MV4-11 (human leukemia), A549 (non-small cell 
lung cancer) and HCT116 (colon cancer) and BALB/3T3 (normal murine fibroblasts). All the N11 
methylated compounds significantly increased the anticancer activity, and also exhibited a 
selective activity.  
3) All the indolo[3,2-c]quinoline derivatives showed potent antimalarial activity against the CQS 
strain (NF54) and the CQR strain (K1) in vitro. The chlorine atom at C2 and urea derivatives 
increased activity against the CQS strain (NF54). The methyl branched pendant decreased 
cytotoxicity and increased antimalarial activity. The linear correlation analysis revealed that there 
were three contributing factors, namely water solubility, hydrophilic surface area, and β-haematin 
inhibition that influence biological activity of this series against CQS (NF54) parasites.  
4) The author described the synthesis of 6-methyl-5H-indolo[2,3-b]quinoline and evaluated their 
antimalarial activity against P.falciparum (NF54), cytotoxicity toward L6 cells and -haematin 
inhibition activity. Introduction of Me group at N6 and modification to the urea and thiourea 
derivatives were not favorable for antimalarial activity, but the cytotoxicity was improved against 
normal cells. 
5) The artemisinin-indoloquinoline hybrids were synthesized and screened for antimalarial activity 
against two different strains (CQS: NF54 and CQR: K1) and the cytotoxicity activity against 
normal L6 cells were evaluated. All hybrids showed significant antimalarial activity 
and β-haematin inhibition activity. 
From these results, it can be seen that the research indicated by this paper is worth as a doctoral 
dissertation (Dr., engineering). 
  
